Annual Operating Profit
-$85.94 M
-$31.23 M-57.08%
31 December 2023
Summary:
Leap Therapeutics annual operaing income is currently -$85.94 million, with the most recent change of -$31.23 million (-57.08%) on 31 December 2023. During the last 3 years, it has fallen by -$57.63 million (-203.59%). LPTX annual operating profit is now -876.70% below its all-time high of -$8.80 million, reached on 31 December 2012.LPTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$18.35 M
+$2.65 M+12.60%
30 September 2024
Summary:
Leap Therapeutics quarterly operating income is currently -$18.35 million, with the most recent change of +$2.65 million (+12.60%) on 30 September 2024. Over the past year, it has dropped by -$4.08 million (-28.54%). LPTX quarterly operating profit is now -346.33% below its all-time high of $7.45 million, reached on 31 December 2015.LPTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$68.78 M
-$4.08 M-6.30%
30 September 2024
Summary:
Leap Therapeutics TTM operating income is currently -$68.78 million, with the most recent change of -$4.08 million (-6.30%) on 30 September 2024. Over the past year, it has increased by +$15.49 million (+18.38%). LPTX TTM operating profit is now -2869.56% below its all-time high of -$2.32 million, reached on 31 March 2013.LPTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPTX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -57.1% | -28.5% | +18.4% |
| 3 y3 years | -203.6% | -68.8% | -87.8% |
| 5 y5 years | -186.5% | -131.4% | -99.6% |
LPTX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -203.6% | at low | -73.2% | +56.8% | -87.8% | +20.6% |
| 5 y | 5 years | -203.6% | at low | -191.5% | +56.8% | -142.9% | +20.6% |
| alltime | all time | -876.7% | at low | -346.3% | +56.8% | -2869.6% | +20.6% |
Leap Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$18.35 M(-12.6%) | -$68.78 M(+6.3%) |
| June 2024 | - | -$21.00 M(+44.0%) | -$64.70 M(+11.4%) |
| Mar 2024 | - | -$14.58 M(-1.8%) | -$58.06 M(-32.4%) |
| Dec 2023 | -$85.94 M(+57.1%) | -$14.84 M(+3.9%) | -$85.94 M(+2.0%) |
| Sept 2023 | - | -$14.28 M(-0.6%) | -$84.27 M(-0.4%) |
| June 2023 | - | -$14.36 M(-66.2%) | -$84.62 M(-2.3%) |
| Mar 2023 | - | -$42.45 M(+222.4%) | -$86.57 M(+58.2%) |
| Dec 2022 | -$54.71 M(+36.1%) | -$13.17 M(-10.0%) | -$54.71 M(+4.4%) |
| Sept 2022 | - | -$14.64 M(-10.3%) | -$52.39 M(+7.7%) |
| June 2022 | - | -$16.31 M(+54.0%) | -$48.63 M(+16.6%) |
| Mar 2022 | - | -$10.60 M(-2.3%) | -$41.69 M(+3.7%) |
| Dec 2021 | -$40.20 M(+42.0%) | -$10.85 M(-0.2%) | -$40.20 M(+9.8%) |
| Sept 2021 | - | -$10.87 M(+15.9%) | -$36.62 M(+10.9%) |
| June 2021 | - | -$9.38 M(+3.1%) | -$33.03 M(+6.2%) |
| Mar 2021 | - | -$9.10 M(+25.3%) | -$31.11 M(+9.9%) |
| Dec 2020 | -$28.31 M(-15.0%) | -$7.27 M(-0.2%) | -$28.31 M(-3.4%) |
| Sept 2020 | - | -$7.28 M(-2.5%) | -$29.31 M(-2.2%) |
| June 2020 | - | -$7.47 M(+18.6%) | -$29.96 M(-3.0%) |
| Mar 2020 | - | -$6.30 M(-23.9%) | -$30.89 M(-7.3%) |
| Dec 2019 | -$33.32 M(+11.1%) | -$8.27 M(+4.3%) | -$33.32 M(-3.3%) |
| Sept 2019 | - | -$7.93 M(-5.6%) | -$34.45 M(-1.1%) |
| June 2019 | - | -$8.40 M(-3.7%) | -$34.82 M(+5.5%) |
| Mar 2019 | - | -$8.72 M(-7.3%) | -$33.02 M(+10.1%) |
| Dec 2018 | -$30.00 M | -$9.40 M(+13.3%) | -$30.00 M(+10.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$8.30 M(+25.9%) | -$27.27 M(+2.6%) |
| June 2018 | - | -$6.59 M(+15.7%) | -$26.60 M(+0.3%) |
| Mar 2018 | - | -$5.70 M(-14.7%) | -$26.52 M(-13.4%) |
| Dec 2017 | -$30.64 M(+26.7%) | -$6.68 M(-12.3%) | -$30.64 M(+6.5%) |
| Sept 2017 | - | -$7.62 M(+16.9%) | -$28.76 M(+2.1%) |
| June 2017 | - | -$6.52 M(-33.5%) | -$28.17 M(-2.3%) |
| Mar 2017 | - | -$9.81 M(+104.0%) | -$28.84 M(+19.3%) |
| Dec 2016 | -$24.18 M(+102.8%) | -$4.81 M(-31.6%) | -$24.18 M(+102.9%) |
| Sept 2016 | - | -$7.03 M(-2.3%) | -$11.91 M(+11.9%) |
| June 2016 | - | -$7.19 M(+39.9%) | -$10.64 M(+4.3%) |
| Mar 2016 | - | -$5.14 M(-169.0%) | -$10.20 M(-14.4%) |
| Dec 2015 | -$11.92 M(-43.0%) | $7.45 M(-229.4%) | -$11.92 M(-55.7%) |
| Sept 2015 | - | -$5.76 M(-14.7%) | -$26.91 M(+0.5%) |
| June 2015 | - | -$6.75 M(-1.6%) | -$26.79 M(+9.7%) |
| Mar 2015 | - | -$6.86 M(-9.0%) | -$24.43 M(+16.8%) |
| Dec 2014 | -$20.92 M(+50.8%) | -$7.54 M(+33.8%) | -$20.92 M(+21.4%) |
| Sept 2014 | - | -$5.63 M(+28.4%) | -$17.23 M(+1.5%) |
| June 2014 | - | -$4.39 M(+30.9%) | -$16.97 M(+13.9%) |
| Mar 2014 | - | -$3.35 M(-13.0%) | -$14.91 M(+7.5%) |
| Dec 2013 | -$13.87 M(+57.6%) | -$3.85 M(-28.3%) | -$13.87 M(+38.5%) |
| Sept 2013 | - | -$5.38 M(+131.9%) | -$10.02 M(+116.0%) |
| June 2013 | - | -$2.32 M(+0.2%) | -$4.64 M(+100.2%) |
| Mar 2013 | - | -$2.32 M | -$2.32 M |
| Dec 2012 | -$8.80 M | - | - |
FAQ
- What is Leap Therapeutics annual operaing income?
- What is the all time high annual operating profit for Leap Therapeutics?
- What is Leap Therapeutics annual operating profit year-on-year change?
- What is Leap Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Leap Therapeutics?
- What is Leap Therapeutics quarterly operating profit year-on-year change?
- What is Leap Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Leap Therapeutics?
- What is Leap Therapeutics TTM operating profit year-on-year change?
What is Leap Therapeutics annual operaing income?
The current annual operating profit of LPTX is -$85.94 M
What is the all time high annual operating profit for Leap Therapeutics?
Leap Therapeutics all-time high annual operaing income is -$8.80 M
What is Leap Therapeutics annual operating profit year-on-year change?
Over the past year, LPTX annual operaing income has changed by -$31.23 M (-57.08%)
What is Leap Therapeutics quarterly operating income?
The current quarterly operating profit of LPTX is -$18.35 M
What is the all time high quarterly operating profit for Leap Therapeutics?
Leap Therapeutics all-time high quarterly operating income is $7.45 M
What is Leap Therapeutics quarterly operating profit year-on-year change?
Over the past year, LPTX quarterly operating income has changed by -$4.08 M (-28.54%)
What is Leap Therapeutics TTM operating income?
The current TTM operating profit of LPTX is -$68.78 M
What is the all time high TTM operating profit for Leap Therapeutics?
Leap Therapeutics all-time high TTM operating income is -$2.32 M
What is Leap Therapeutics TTM operating profit year-on-year change?
Over the past year, LPTX TTM operating income has changed by +$15.49 M (+18.38%)